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Abstract 
 
Background: Transverse colon malignancies have been excluded from all randomized controlled 
trials comparing laparoscopic against open colectomies, potentially due to the advanced 
laparoscopic skills required for dissecting around the middle colic vessels and the associated 
morbidity. Concerns have been expressed that the laparospopic approach may compromise the 
oncological clearance in transverse colon cancer. This study aimed to comprehensively compare 
the laparoscopic (LPA) to the open (OPA) approach by performing a meta-analysis of long and 
short term outcomes. 
 
 
Methods: Medline, Embase, Cochrane library, Scopus and Web of Knowledge databases were 
interrogated. Selected studies were critically appraised and the short-term morbidity and long 
term oncological outcomes were meta-analyzed. Sensitivity analysis according to the quality of 
the study, type of procedure (laparoscopic vs laparoscopically assisted) and level of 
lymphadenectomy was performed. Statistical heterogeneity and publication bias were also 
investigated. 
 
 
Results: Eleven case control trials (1415 patients) were included in the study. There was no 
difference between the LPA and the OPA in overall survival [Hazard Ratio (HR)=0.83 (0.56, 
1.22); P=0.34], disease free survival (p=0.20), local recurrence (p=0.81) or distant metastases 
(p=0.24).  LPA was found to have longer operative time [Weighted mean difference 
(WMD)=45.00 (29.48, 60.52);P<0.00001] with earlier establishment of oral intake [WMD=-1.68 (-
1.84, -1.53);P<0.00001] and shorter hospital stay [WMD =-2.94 (-4.27, -1.62);P=0.0001]. No 
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difference was found in relation to anastomotic leakage (p=0.39), intra-abdominal abscess 
(p=0.25), lymph nodes harvested (p=0.17). 
 
Conclusions: LPA seems to be safe with equivalent oncological outcomes to OPA and better 
short term outcomes in selected patient populations. High quality Randomized control trials are 
required to further investigate the role of laparoscopy in transverse colon cancer.   
 
Highlights:  
• 11 studies comparing the open to the laparoscopic approach were pooled 
• The laparoscopic approach carries significant short term benefits with the same disease 
free and overall survival 
• Laparoscopic high tie of the middle colic vessels appears to be a safe and feasible 
technique 
 
Keywords: transverse colon cancer, laparoscopic, minimally invasive, neoplasia, surgery 
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Introduction 
 
The laparoscopic technique in colonic cancer surgery has significant benefits compared to the 
open technique, such as shorter hospital stay, less post-operative pain and earlier return to 
normal activity with similar oncological outcomes[1-5].  All the randomized control trials[5,1,4,2,6] 
that compared open with laparoscopic colectomy for colon cancer though excluded cancers 
located in the transverse colon. The potential reason for this has been the perceived increased 
difficulty of laparoscopic lymph node dissection around the middle colic artery and vein, the 
potential for increased intraoperative complications because of the close proximity of the 
transverse mesocolon to structures such as the duodenum, the pancreas and the superior 
mesenteric artery, as well as the low incidence of transverse colon cancer[7,8]. A number of 
studies have suggested that the laparoscopic approach may compromise the oncological 
clearance of the tumour and provide a less radical dissection of the transverse mesocolon[9-11] 
especially when the aim is complete mesocolic excision at the transverse mesocolon. 
Over the last few years the increasing experience in laparoscopic colonic resections among 
surgeons has led to the cumulative publication of several studies comparing the oncological 
outcomes of the open to the laparoscopic approach for transverse colon cancer. The aim of this 
study therefore was to systematically review the literature and identify all the studies comparing 
the open and the laparoscopic approach in the resection of transverse colon cancer, critically 
review all the available evidence and provide a comprehensive comparison of the laparoscopic to 
the open approach by comparing short and long term outcomes and compare high vs low tie in 
transverse colon cancer. 
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Methods 
 
This systematic review and meta-analysis followed the PRISMA guidelines Supplementary Figure 
1 [12]. A protocol was available to all the authors of the study. 
 
Inclusion and exclusion criteria 
All randomized or case control trials comparing the open to the laparoscopic colectomy 
techniques for histologically proven transverse colon adenocarcinoma were included in the study. 
Transverse colon cancer was defined as cancer involving the transverse colon excluding the 
hepatic and the splenic flexure. Studies that compared open with hand-assisted laparoscopic 
colectomies were excluded. For duplicate studies the most up to date study was included (see 
PRISMA flow chart). 
 
The primary outcome of the study was 5 year overall survival. Outcomes such as 5 year disease 
free survival, anastomotic leakage, intraoperative blood loss, operating time, time to first oral 
intake, length of hospital stay, overall morbidity and mortality were also compared between the 
two groups. 
 
Search Strategy 
Medline, Embase, Cochrane library, Scopus and Web of Knowledge databases were searched by 
two independent authors for studies comparing open with the laparoscopic approach for 
transverse colon cancer from 1990 to July 2016. CAB abstracts (1990-2016) and Asco University 
libraries were also searched for abstracts. The following Mesh terms were used: “transverse 
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colon adenocarcinoma”, “transverse colon neoplasia”, “transverse colon malignancy”, “transverse 
colectomy”, “extended right hemicolectomy”, “extended left hemicolectomy”, “laparoscopy”, 
“laparoscopic”, “minimally invasive” and “open” with no language restrictions. The results of the 
electronic search were screened through the title, abstract and/or a full publication review.  
 
Data abstraction and validity assessment 
The data from the selected studies were extracted by two independent authors to predefined 
tables. The tables included but were not limited to independent variables, patient characteristics, 
paper statistics, short and long term outcomes quality assessment of included studies as per 
Cochrane Handbook[13] and Newcastle Ottawa Scale(NOS) [14].The quality assessment of the 
studies was performed independently by two authors. 
 
Statistical Analysis 
For continuous data weighted mean difference (WMD) and 95% confidence intervals (CI) were 
calculated. In studies that did not report mean and standard deviation values for their continuous 
data an estimate was calculated[15]. For dichotomous data an odds ratio (OR) and 95% CI were 
calculated. An OR of less than 1 favored the laparoscopic approach. HR was used for disease 
free survival and overall survival data. A hazard ratio (HR) of less than 1 favored the laparoscopic 
approach. For studies that did not report a HR an estimate was calculated from the Kaplan Meier 
curve[16,17]. Subgroup analysis was done for high and low quality studies, totally laparoscopic vs 
laparoscopically assisted and high versus low tie of the middle colic vessels. High quality studies 
were considered the studies scoring more than 8 in the NOS. Sensitivity analysis was performed 
excluding studies that reported a laparoscopically assisted technique, low quality studies and low 
tie. Meta-regression was not performed as the number of studies was low. I2 and χ2 were used to 
assess statistical heterogeneity. If it was found to be above 50% the random effect model was 
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
6 
 
used for the analysis.  Publication bias was assessed by visual interpretation of the symmetry of 
the funnel plots. 
 
 
Results 
Selection and quality assessment 
Eleven case control trials[8,7,18-26] fulfilled the inclusion and exclusion criteria including 652 
patients in the open group and 763 patients in the laparoscopic group. Four studies were 
excluded two studies because they included tumours of the splenic flexure[27,28], one study 
because the comparative group included tumours of the descending colon[29] and one because a 
more up to date study by the same authors was published[30] Figure 1.A summary of the 
included studies is provided in Table 1. Overall survival, disease free survival were reported in 7 
studies and recurrence data were reported in five studies[21,20,7,22,24] one of which was 
multicentric[21].  
Most of the patients included in the studies were in their late fifties or early sixties apart from the 
patients in 3 studies [23,7,8]which were in their late sixties to early seventies. Six studies 
[21,22,24,7,8] [25]reported an American Society of Anesthesiologists Score.  Patients with ASA III 
score ranged variably from 0% to 41.8%. Body Mass Index (BMI) was reported in seven 
studies[21,24,7,19,18,25,26] and the mean value ranged from 21.7 to 24.2 (Table 2). 
 
The surgical approach in most studies included right extended hemicolectomy, transverse 
colectomy and left extended hemicolectomy for transverse colon cancer. In five of the studies 
[8,23,19,20,25] a small number of subtotal colectomies were performed. In the laparoscopic 
approach subtotal colectomies ranged from 1.3 to 11.7%. Only two studies[20,19] report a 
subtotal colectomy in the open approach and the percentage varied greatly from 4.3% to 23%. 
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Laparoscopic transverse colectomy varied between 2.9% and 59% of the cases. In seven 
studies[18,21,20,24,23,25,26] the authors performed high tie of the vessels routinely and in one 
study[22] high tie was only done for T3N1 disease. All the studies apart from two[23,22] reported 
their conversion rates which ranged from 1.9% to 16.7%. Four of the studies [18,8,7,26] reported 
on the experience of the surgeons that performed the procedure. 
 
All the studies apart from one[18] provide data on the stage of the disease. Nine studies reported 
the stage according to the TNM and one study[8]according to the Dukes classification. In the 
laparoscopic group stage III disease ranged from 22% to 51.4%. Stage IV disease was reported 
in two studies. Mean follow up ranged from 33 to 71 months. Five of the studies[23,24,7,25,26] 
reported on the use of chemotherapy. Most of the reported outcomes were not clearly defined. 
The quality of studies (Newcastle Ottawa Score) can be found on Table 1. The studies were 
found to be sufficiently homogeneous to meta-analyze their results. 
 
Meta-analysis 
Funnel plot visual interpretation did not reveal any publication bias in any of the reported 
outcomes. 
 
Mortality 
Nine studies[21,20,23,22,24,19,18,7,26] reported their mortality data. Seven of the studies 
reported no mortality.  No significant difference was found between the open and the 
laparoscopic approach [OR=1.36 (0.22, 8.44); P=0.74]. The incidence for the laparoscopic group 
was 0.4%(3/662) and 0.3% (2/605) for the open approach. 
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Anastomotic leakage 
 
Anastomotic leakage was reported in all but one[25] of the studies. There was no statistical 
heterogeneity I2=0 between the studies. No difference was found between the open and the 
laparoscopic approach [OR=0.72 (0.33, 1.53); P=0.39] (Figure 2). 
 
Intra-abdominal abscess 
Six of the studies [21,23,24,19,8,26] reported this outcome. No heterogeneity was present I2=0. 
No statistical significant difference was found between the two groups [OR=0.60 (0.25, 1.42); 
P=0.25]. 
 
Wound infection 
Six of the studies[21,23,24,19,8,18,26] reported this outcome. No heterogeneity was found 
between studies I2=0. No statistical significant difference was found between studies [OR=1.15 
(0.50, 2.64); P=0.74]. 
 
Operative time 
Nine studies[21,20,22,24,7,19,18,26,25] reported this outcome. In all but one[7] the laparoscopic 
approach lasted longer. Significant heterogeneity was present (I2 =93%). The random effect 
model was used. There was statistically significant difference between the two groups favoring 
the open approach [WMD=45.00 (29.48, 60.52); P<0.00001]. 
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Time to oral intake 
Eight studies[18,19,22,21,7,24-26] reported this outcome. In four[22,19,18,26] of them it was 
defined as time to liquid diet. In the other four [21,7,24,25] there was no clear definition. In two 
studies[26] [7] oral diet was started after passing flatus and in another[21] time to soft diet is 
reported. Time to liquid diet was significant shorter for the laparoscopic group with a [WMD=-1.23 
(-1.48, -0.98); P<0.00001 but with high heterogeneity I2=79%. When all the studies are included 
in the outcome there is still statistically significant difference between the two groups with a 
[WMD=-1.68 (-1.84, -1.53); P<0.00001] favoring the laparoscopic approach but with 
heterogeneity of I2=93% (Figure 3). 
 
Re-operation 
Six of the studies [23,24,7,20,8,26] reported this outcome. There was no statistical heterogeneity 
between the studies I2=0. No statistically significant difference was found [OR=0.71 (0.33, 1.52); 
P=0.38]. 
 
Length of hospital stay 
All but one[8] of the studies reported this outcome. Significant heterogeneity was present with a 
I2=81%. The random effect model was used. There was a statistical significant difference in favor 
of the laparoscopic approach with a [WMD=-2.94 (-4.27, -1.62); P=0.001] (Figure 4). 
 
Lymph nodes harvest 
All the studies reported this outcome. High degree of heterogeneity was present between studies 
(I2=73%). The random effect model was used. No difference between the two groups was found 
but there was a tendency favoring the laparoscopic approach [WMD=-1.19 (-2.89, 0.50); P=0.17].  
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Overall Survival 
Seven studies [21,20,22,24,7,25,26] reported this outcome. No statistical heterogeneity was 
present I2=0. No statistically significant difference was found between the two groups [HR=0.83 
(0.56, 1.22); P=0.34] (Figure 5). 
 
Disease free survival 
The same seven studies [21,20,22,24,7,26,25] as above reported this outcome. No statistical 
heterogeneity was found between the two groups (I2=0). No statistically significant difference 
between the two groups was found HR= [0.82 (0.60, 1.11); P=0.20]. 
 
Local recurrence  
Five studies [21,23,22,20,19] reported this outcome. No statistical heterogeneity was present 
I2=0. No statistically significant difference was found between the two groups with an OR= [1.13 
(0.42, 3.07); P=0.81] 
 
Distant Metastases 
The same studies [21,23,22,20,19] as above reported this outcome. As above there was no 
statistical heterogeneity. No statistically significant difference was found between the two groups 
I2=0 with an OR=[0.70 (0.39, 1.26); P=0.24]. 
 
The subgroup analysis performed for high quality studies, totally laparoscopic studies and high tie 
did not alter the level of significance in any of the above results.  
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Discussion 
 
Our study is the first to report meta-analytical data on overall survival, disease free survival, local 
recurrence and distant metastasis and to compare extended vs conventional lymphadenectomy 
in transverse colon cancer. The laparoscopic approach appears to retain its significant benefits 
seen in right and left colectomy techniques, such as shorter hospital stay and time to oral diet 
with equivalent overall and disease free survival. These benefits remain in the extended 
lymphadenectomy group. Equivalent local recurrence and metastatic disease development were 
also found between the two groups. 
 
An extremely low mortality of 0.4% was reported overall in this group of studies, potentially an 
indicator of the high quality of surgery performed with only two of the studies reporting fatalities as 
the rest of the studies had reported a morality of zero. The low reported mortality though may also 
be an indicator of an inherent selection bias supported by the low BMI reported in seven 
[26,25,21,24,7,19,18] of the studies and the poor reporting of ASA score which can affect the 
external validity of the studies. Higher BMI levels usually found with North American and 
European patients may make the laparoscopic approach more difficult.  
 
As expected laparoscopic resections were found to take longer time to complete, reflecting the 
difficulty of the laparoscopic dissection and the potential prolonged learning curve required to 
master this type of anatomical resection. Although there was high heterogeneity in relation to this 
outcome, part of it might be explained by the fact that in only one study [7] the laparoscopic 
procedures lasted the same time as the open. Conversion rates varied from 1.9% to 16.7% but in 
most of the studies the conversion rate was less than 5% which does not differ from what is 
expected from the literature [31,32], indicating a good level of experience of the laparoscopic 
surgeons involved in these studies. 
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There was no difference in the anastomotic leakage or in the intra-abdominal abscess rates 
between the two groups, with similar reoperation rates. None of the included studies reported on 
the use of an enhanced recovery protocol (ERP) or reported their discharge criteria raising the 
potential risk for observational bias. A further factor influencing the length of stay is the country in 
which the study was performed. Out of eleven studies nine [21,20,22,24,18,25,26] are of Eastern 
Asian origin and three[23,7,19] are from Europe. As previously described, [33] socioeconomic 
reasons may delay the decision of discharge in studies of Asian origin. These factors may have 
contributed to the high heterogeneity observed in the meta-analysis of the length of stay outcome. 
Furthermore, they can affect the external validity of the overall findings when related to countries 
employing ERPs with early discharge criteria. Within individual studies though reported data still 
indicated a shorter length of stay in the laparoscopic group.  
 
The laparoscopic group had shorter time to oral intake but this outcome was again poorly defined 
as some studies reported the time to liquid diet, others the time to soft diet and some did not 
define it at all. Individually again most studies indicated earlier timings in the laparoscopic groups 
and is consistent with the faster discharge from hospital reported in this group of patients.  
 
The number of lymph nodes harvested with the specimen is often used as a surrogate marker of 
surgical quality with a set standard of high quality care of at least 12 lymph nodes[34]. All the 
studies had a mean number of lymph nodes that exceeded this standard providing another 
surrogate marker of the quality of the laparoscopic resection. In all but three studies [19,7,8] the 
authors reported that they performed a high tie of the feeding vessels. In Japan D3 
lymphadenectomy is the standard of care for stage II/III colon cancer[35]. A recent review has 
indicated that laparoscopic extended lymphadenectomy for colon cancer does not add in 
morbidity compared to the open approach and has similar long term outcomes[36]. Routine 
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laparoscopic dissection around central mesenteric vessels to achieve a high tie can prepare 
surgeons in gaining the advanced laparoscopic skills needed to perform lymph node dissection 
around the middle colic artery and the difficult mobilization of the transverse colon. 
 
In relation to the oncological outcomes of overall survival and disease free survival reported 
results were excellent for both groups. The follow-up period beyond the 2 years with some 
studies reporting data on a 71-month period is also very good. The results though are weakened 
by the absence of reporting and potential control of the adjuvant treatment regimes employed in 
most studies which can have a direct influence on these outcomes, especially in patients with 
stage III disease. 
 
The inclusion of non-randomized studies and the possible selection bias that these may introduce 
to the meta-analysis, even though this is the only level of evidence currently available should be 
considered as one of its limitations. Some of the outcomes were poorly defined and this may be 
one of the reasons that outcomes such as length of stay, time to oral intake and operative time 
indicated high heterogeneity, as already described. Calculation bias might be present in the 
overall and disease free survival outcomes as HRs were not reported in any of the studies but 
were calculated using statistical methods [16]. 
 
Overall, the reviewed evidence suggests that laparoscopic colectomy for transverse colon cancer 
is feasible and safe when performed by experienced surgeons. It also carries the benefits of other 
laparoscopic colonic resection techniques such as faster oral intake and discharge while having 
equivalent morbidity, mortality, overall and disease free survival when compared to the open 
approach (level IIIa evidence) [37]. Further higher level of evidence is required to support these 
findings, but in the current era and evidence in favor of the laparoscopic technique it would only 
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be ethical for these to be obtained through high quality prospective trials rather than randomized 
controlled trials.  
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Table & Figure legends. 
 
Table 1. Summary of studies investigating open versus laparoscopic colectomy for transverse colon cancer 
Table 2. Studies’ significant independent variables/external validity comparison 
 
Figure 1. PRISMA 2009 Flow Diagram 
 
Figure 2. Anastomotic leakage forest plot 
 
Figure 3. Time to oral intake 
 
Figure 4. Length of hospital stay forest plot 
 
Figure 5 Overall survival forest plot 
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Table 1. Summary of studies investigating open versus laparoscopic colectomy for transverse colon cancer 
 
Study Design Type of 
procedure 
Outcomes that 
were defined In 
studies 
Inclusion criteria Exclusion criteria Transverse colon 
cancer definition 
OP 
 (n) 
LP 
 (n) 
Follow up NOS 
S-C-O 
Kim 2016 CCT-       
6-Korea 
RH, LH ,TC LR, SR, OS, DFS Consecutive patients from 
01/05-02/15 
Recurrent cancer, FAP or 
HNPC, or stage 0 and IV , 
emergency or palliative 
colectomies 
Between hepatic 
and splenic 
flexure 
123 103 Lap:   46m 
OP: 54m 
 
4-1-3 
Storli 2016 CCT 
1-Norway 
ERH, TC, 
ELH, ST,  
Mortality and 
oncological 
outcomes 
Consecutive patients from 
01/07- 05/14  
Tumours in the flexures, 
not achieving CME 
 
Between hepatic 
and splenic 
flexure 
23 33 Lap: 
46.1m 
(median) 
OP:79.5 m 
(median) 
3-1-2 
Kim 2015 CCT 
1-Korea 
RH, ERH, 
TC, LH, 
ELH, ST 
ND Consecutive patients from  
04/96- 02/09 
Stage 0/I/IV, emergency 
procedure, concurrent 
cancer, previous 
malignancy, staged 
operation, R1 resection, 
hereditary colon cancer  
Between the 
hepatic and 
splenic flexure 
23 79 Lap: 
67.5m 
(median) 
OP: 132m 
(median) 
3-1-2 
Sheng 2015 CCT 
1-China 
ERH,ELH, 
TC 
mortality Histologically proven TCC, 
ECOG 0-1, clinical stage of 
cT1-3N0-1M0 
Emergency and palliative 
resections 
NA 59 59 (10-107m) 4-2-2 
Zeng 2015 CCT 
1-China 
ERH, ELH, 
TC 
 
DFS, OS Consecutive patients from 
01/06- 06/14 
Emergency colectomies, 
stage IV disease, non-
radical or multiple organ 
resections 
Between hepatic 
and splenic 
flexure 
122 156 Lap: 39 m       
(1–90 m) 
OP: 44 m        
(1–98 m) 
4-1-2 
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Mistrangelo 
2014 
CCT 
1-Italy 
ERH, ELH, 
TC 
 
ND Consecutive patients 
(biopsy proven 
adenocarcinoma) from 
04/98 and 04/ 11 
 
Emergency colectomies 
for obstruction, 
perforation, acute 
bleeding, or unable to 
tolerate GA, invasion of 
adjacent organs (for the 
LAP group) 
 
 
Between hepatic 
and splenic 
flexure 
57 66 LP:67m   
(24–156) 
OP:71m 
(24–156) 
4-1-2 
Kim 2014 CCT 
1-Korea 
ERH, ELH, 
TC, ST 
ND Consecutive patients from 
01/06 to 12/10 (pTNM 
stage I-III) 
Previous malignancy, 
two primary cancer and 
those lost to follow-up 
(10 patient) 
Between hepatic 
and splenic 
flexure 
47  
 
84  
 
OC:58 m 
(10-85) 
LAP: 42 m 
(7-82) 
4-1-2 
Zhao 2014 CCT 
1-China 
ERH, ELH, 
TC 
ND Consecutive patients from 
01/02 to 06/11 
Stage 0/I/IV, recurrent 
disease, emergency 
colectomy, palliative 
surgery 
Between hepatic 
and splenic 
flexure 
83 74 OP:58m 
(median) 
LAP:54m 
(median) 
3-1-2 
Fernandez-
Cebrian 
2013 
CCT 
1-Spain 
NR Operative time, 
intra-operative 
blood loss 
Consecutive patients from 
03/98 to 12/09 
Emergency colectomies, 
local invading tumours, 
simultaneous 
metastasectomy, non-
curative resection, TNM 
Stage IV 
 
NR 52 34 33 ±2.3 m 4-1-2 
Akiyoshi 
2010 
CCT RH, LH, TC ND Consecutive patients 
07/05 to 10/09 
Non-curative resection 
(19 patients) or with 
Between hepatic 
and splenic 
39  53 No follow 
up 
4-0-2 
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1-Japan synchronous resection 
(17 patients) 
flexure 
Zmora 2010 CCT 
1-Israel 
ERH, ST, 
TC, LC 
ND Lap: between 1999 and 
2005 compared to patients 
from 1997 to 2000 in the 
open approach 
NR Between hepatic 
and splenic 
flexure 
24 22 NR 3-0-2 
 RH: Right hemicolectomy, ERH: extended right hemicolectomy, ELH: extended left hemicolectomy, LH: Left hemicolectomy, TC: transverse colectomy, ST: 
subtotal colectomy, TCC: transverse colon cancer, LR: local recurrence, SR: systemic recurrence,  ND: outcomes not well defined, GA: General anesthetic, 
pTNM: pathologic tumour, node and metastasis stage,  CME: complete mesocolic excision, ECOG: Eastern Cooperative Oncology Group performance 
status, RCT: randomized control trial, case-control trial, CCT: case-control study, CS: case series, OP: open, LAP: laparoscopic, PE: primary endpoint, NR: 
not reported, FAP: familiar adenomatous polyposis, HNPC: Hereditary non polyposis colorectal cancer, m: month(s), d: day(s), NOS: Newcastle Ottawa, 
Scale, S-C-O: Selection-Comparability-Outcome/Exposure   
Data reporting: mean ± standard deviation, Med: median (range), data in ( ): represent range 
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Table 2. Studies’ significant independent variables/external validity comparison 
Study Age Gender M/F ASA score Pathological clinical stage 
     
  T N M Stage 
 OP LP OP LP OP LP OP LP OP LP OP LP OP LP 
Kim 2016 62.8 ± 14.0 
 
 
65.6 ± 12.1 
 
66/57 
 
68/35 
 
I  20 
(16.4%)        
 
20 (19.4%) 
 
NR 
 
NR NR NR NR NR  
I  18 
(14.6%)   
 
 
 
26 
(25.2%) 
II 80 
(65.6%)        
 
58 (56.3%) II  58 
(47.5%)   
 
45 
(43.3%) 
III 21 
(17.2%)        
24 (23.3%) III 47 
(38.5%)   
 
32 
(30.8%) 
IV 1 
(0.8%)          
 
1 (1.0%) 
Storli 2016 68.0 ± 13.3 73.0 ± 11.4 10/13 11/22 NR NR T1  3 
(13.0%) 
 
2 (6.1%) 
 
NR NR NR NR I  4 
(17.4%)      
 
4 (12.1%) 
T2  3 
(13.0%) 
 
4 
(12.1%) 
 
II 11 
(47.8%)   
16(48.5%) 
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T3 16 
(69.6%) 
 
26 
(78.8%) 
 
III 8 
(34.8%)    
13(39.4%) 
T4 1 
(4.3%) 
1 (3.0%) IV: NR NR 
Kim 2015 56.0 ± 15.9 65.7  ± 10.0 16/7 45/34 I 
15(66.2%) 
39(49.4%) I+II 0 0 0 15 
(65.2
%) 
48 
(60.8
%) 
0 0 I 0 0 
II 8 
(34.8%) 
39(49.4%) III 21 
(91.3%) 
74 
(93.7%) 
1 6 
(26.1
%) 
24 
(30.4
%) 
II 15 
(65.2%) 
48 
(60.8%) 
III 0 (0%) 1(1.3%) IV 5 
(6.3%) 
2 (8.7%) 2 2 
(8.7%) 
7 
(8.9%) 
III 8 
(34.8%) 
31 
(39.2%) 
Sheng 2015 61 (43-72) 
 
60 (41-75) 
 
32/ 27 
 
34/ 25 
 
I      
37(62%) 
 
36(61%) 
 
NR NR NR NR NR NR I         
7(11%) 
 
6(10%) 
 
II     20 
(33%) 
 
21(35%) 
 
II       
28(47%) 
 
26(44%) 
 
III    
2(3%) 
2(3%) III      
24(40%) 
27(45%) 
Zeng 2015 med58 (26–
85) 
58 (26–84) 55/67 71/85 I    12 
(9.8%) 
 
21 (13.5%) 
 
NR NR NR NR NR NR I    12 
(9.8%) 
 
19 
(12.2%) 
 
II  57 67 (42.9%) II  58 77 
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(46.7%) 
 
 (47.5%) 
 
(49.4%) 
 
III 51 
(41.8%) 
 
64 (41.0%) 
 
III 52 
(42.6%) 
60 
(38.5%) 
IV 2 
(1.6%) 
   4 (2.6%) 
 
IV: NR NR 
Mistrangelo 
2014 
med70 (49–
90) 
68 (37–90) 33 /24 32 /34 I 17 
(29.8%) 
 
21 (31.8%) 
 
T1  2 
(3.5%) 
 
11 
(16.7%) 
 
NR NR NR NR I  9 
(15.8%) 
 
15 
(22.7%) 
 
II 27 
(47.4%) 
 
34 (51.5%) 
 
T2 7 
(12.3%) 
 
7 
(10.6%) 
 
II 26 
(45.6%) 
 
25 
(37.9%) 
 
III 11 
(19.3%) 
 
10 (15.2%) 
 
T3 31 
(54.4%) 
 
43 
(65.2%) 
 
III 13 
(22.8%) 
 
18 
(27.3%) 
 
IV 2 
(3.5%) 
1(1.5%) T4 17 
(29.8%) 
5 (7.6%) IV 9 
(15.8%) 
8 (12.1%) 
Kim 2014 59.7 ± 13.2 
 
62.3 ± 11.6 
 
27/20 
 
45/39 
 
NR NR NR NR 
 
 
NR NR NR NR I: 6 
(12.7%)  
 
28 
(33.3%)  
 
II: 21 
(44.7%)  
 
37 
(44.0%) 
 
III: 20 
(42.6%)  
 
19 
(22.6%) 
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Zhao 2014 55.7 ±  14.8 54.0 ± 14.8 48/35 43/31 NR NR NR NR NR NR NR NR II 45 
(54.2%) 
36 
(48.6%) 
III 38 
(45.8%) 
38 
(51.4%) 
Fernandez-
Cebrian 2013 
62.4± 6.8 60.3 ±8.1 25/27 21/13 NR NR NR NR NR NR NR NR I 7 
(13.4%) 
 
5 (14.7%) 
 
 
II 24 
(46.1%) 
 
13 
(38.2%) 
III 
21(40.4%) 
16 (47%) 
Akiyoshi 2010 62 (24–86) 66 (36–88) 21/18 32/21 NR NR Is 0 
T1:  0 
 
3 (6%) 
10 (19%) 
0:  22 
(56%) 
 
33 
(62%) 
 
NR NR NR NR 
T2  3 
(8%) 
 
15 (28%) 
 
1:13 
(33%) 
 
15 
(28%) 
 
T3  29 
(74%) 
 
11 (21%) 
 
2: 4 
(10%) 
5 (9%) 
T4   7  
(18%) 
14 (26%) 
 
  
Zmora 2010 70.5        68 12/12 14/8 2.5(mean 
ASA) 
2.1(mean 
ASA) 
NR NR NR NR NR NR Dukes  
 A 1 (4%) 
 
 
2 (9%) 
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B 14 
(58%) 
13 (59%) 
 
C 8 (33%) 5 (23%) 
 
D 1 (4%) 2 (9%) 
 
M: male, F: female, ASA: American Society of Anaesthesiology score, NR: not reported, NA; not applicable, Is: in situ 
Data reporting: mean ± SD, Med ( ): median (range), N ( ): number and percentage, Stage reported as TNM unless otherwise specified 
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Figure 1. PRISMA 2009 Flow Diagram 
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